Results Timeline and Expectations Understanding the realistic timeline for AOD-9604 effects helps set appropriate expectations and determine whether the peptide is producing its intended metabolic changes
Because of this, the manufacturer Pfizer will not continue studying the twice daily regimen
Because large studies did not show robust, reproducible weightloss outcomes, development as a formal obesity drug was discontinued, and AOD9604 today is typically used offlabel as a wellness or bodycomposition adjunct rather than an FDAapproved obesity medication
Empower Pharmacy formulations tend to follow standard B12 concentrations, producing a predictable medium pink
This process can compromise physical performance, slow down metabolism, and reduce overall resilience
Updated on Are B12 injections painful